ID: ALA4798169

Max Phase: Preclinical

Molecular Formula: C28H38BrN9O7

Molecular Weight: 692.57

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC(C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3cc(Br)ccc23)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC1=O

Standard InChI:  InChI=1S/C28H38BrN9O7/c1-13(2)23-27(45)36-17(4-3-7-32-28(30)31)24(42)34-12-21(39)35-20(10-22(40)41)25(43)37-19(26(44)38-23)8-14-11-33-18-9-15(29)5-6-16(14)18/h5-6,9,11,13,17,19-20,23,33H,3-4,7-8,10,12H2,1-2H3,(H,34,42)(H,35,39)(H,36,45)(H,37,43)(H,38,44)(H,40,41)(H4,30,31,32)/t17-,19+,20-,23-/m0/s1

Standard InChI Key:  PWDSDBVBKCIRHN-USKVXJDGSA-N

Associated Targets(Human)

Integrin alpha-V/beta-3 2708 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Integrin alpha-5/beta-1 686 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 692.57Molecular Weight (Monoisotopic): 691.2078AlogP: -1.06#Rotatable Bonds: 9
Polar Surface Area: 260.49Molecular Species: ZWITTERIONHBA: 7HBD: 10
#RO5 Violations: 2HBA (Lipinski): 16HBD (Lipinski): 11#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.97CX Basic pKa: 12.68CX LogP: -3.04CX LogD: -3.04
Aromatic Rings: 2Heavy Atoms: 45QED Weighted: 0.09Np Likeness Score: 1.00

References

1. Kemker I,Schröder DC,Feiner RC,Müller KM,Marion A,Sewald N.  (2021)  Tuning the Biological Activity of RGD Peptides with Halotryptophans†.,  64  (1.0): [PMID:33356253] [10.1021/acs.jmedchem.0c01536]

Source